Gene description
Orthologous
GO biological process
oxidation-reduction process
GO cellular component
cytoplasm
GO molecular function
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors, metal ion binding
Protein domain
Pfam | PF14226, non-haem dioxygenase in morphine synthesis N-terminal |
Pfam | PF03171, 2OG-Fe(II) oxygenase superfamily |
KEGG pathway
Not involved in KEGG pathway
Transcriptional regulation
Regulator:
AT1G51600, AT3G16857, AT4G16110, AT4G18770, AT5G61850
Target:
none
Protein-protein interaction network
No Interactor
Coexpression network
Differentially expressed condition
9 conditions
Series | Control | Treatment | Log2FC | Adj. P value |
---|---|---|---|---|
GSE37269 | Di2, WT, control | Di2, WT, TEV 21 d | -1.96 | 1.28E-02 |
GSE37269 | Ei2, WT, control | Ei2, WT, TEV 21 d | -3.36 | 2.02E-06 |
GSE37269 | Ler0, WT, control | Ler0, WT, TEV 21 d | -1.51 | 4.32E-02 |
GSE37269 | Wt1, WT, control | Wt1, WT, TEV 21 d | -2.29 | 1.85E-03 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 4 h | 2.21 | 4.00E-12 |
GSE45212 | Col, WT, PstDC3000 AvrRpt2 0 h | Col, WT, PstDC3000 AvrRpt2 8 h | 1.57 | 1.43E-10 |
GSE45214 | Col, med14, PstDC3000 AvrRpt2 0 h | Col, med14, PstDC3000 AvrRpt2 4 h | 2.22 | 7.80E-09 |
GSE45214 | Col, med16, PstDC3000 AvrRpt2 0 h | Col, med16, PstDC3000 AvrRpt2 4 h | 2.60 | 3.12E-10 |
GSE5520 | Col, WT, control 24 h | Col, WT, PstDC3000 24 h | 1.98 | 4.15E-06 |
Copyright © 2017 Ziding Zhang's Lab - China Agricultural University. All Rights Reserved.